Dr. Georg Hiltensperger
About Dr. Georg Hiltensperger
Dr. Georg Hiltensperger is a Senior Medical Manager Oncology - Precision Medicine at Bristol Myers Squibb in München, Bayern, Deutschland, with extensive experience in the pharmaceutical industry and a strong focus on individualized cancer treatment concepts.
Current Position at Bristol Myers Squibb
Dr. Georg Hiltensperger currently holds the position of Senior Medical Manager Oncology - Precision Medicine at Bristol Myers Squibb. Based in München, Bayern, Deutschland, he is responsible for leading initiatives within the oncology sector that focus on personalized cancer treatment strategies. His role includes overseeing the application of precision medicine approaches to optimize patient outcomes.
Previous Roles at Bristol Myers Squibb
Dr. Hiltensperger has progressed through multiple roles at Bristol Myers Squibb. From 2019 to 2021, he served as the Medical Advisor Oncology - Precision Medicine, where he contributed to significant advancements in personalized cancer therapies. Prior to this, he held the position of Jr. Product Manager Immuno-Oncology from 2017 to 2019, in which he managed projects related to immuno-oncology, showcasing his expertise in the field.
Experience in Medicinal Chemistry
Before joining Bristol Myers Squibb, Dr. Hiltensperger gained substantial experience in medicinal chemistry. He worked as a Scientist at BioNTech AG from 2016 to 2017 and held a similar role at 4SC AG from 2015 to 2016. Additionally, he started his career at 4SC AG as a Post Doc in Medicinal Chemistry from 2014 to 2015. These positions allowed him to deepen his understanding of drug development processes and therapeutic discovery.
Educational Background
Dr. Hiltensperger earned his Dr. rer.nat. in Chemistry from Julius-Maximilians-Universität Würzburg, completing his studies from 2003 to 2013. His decade-long academic pursuit provided a solid foundation in chemical sciences, which has underpinned his subsequent work in pharmaceutical research and development. His education equipped him with the technical expertise necessary for his roles in medicinal chemistry and oncology.
Expertise in Precision Medicine and Cancer Therapy
Dr. Hiltensperger's career is marked by his extensive experience in the pharmaceutical industry, with a particular focus on immuno-oncological therapies. His deep understanding of precision medicine allows him to drive forward individualized cancer treatment concepts. By leveraging unique patient characteristics, he aims to tailor cancer therapies, thereby improving treatment outcomes. His professional expertise is motivated by a strong desire to enhance cancer treatment strategies continually.